Retraction
IMPDH2 is highly expressed in breast cancer and predicts unfavourable prognosis
Paper Information
Record ID:
24138
Author(s):
Journal:
Publication Date:
July 02, 2018
Retraction Date:
September 01, 2020
(5.2 years years ago)
Subjects:
Institution:
The Third Department of Internal Medicine, Jilin Provincial Tumor Hospital, Changchun, 130012, ChinaCountry:
šØš³ ChinaArticle Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reason:
Nature of Retraction:
Retraction
Retraction Notice:
10.1080/1354750X.2020.1809831Citations (11)
11
Total Citations3
Post-Retraction(27.3%)
7
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
3
Within 1 year
0
After 2+ years
224
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
JesĆŗs Troya, Paul Bastard, Laura PlanasāSerra et al. (11 authors)
Journal of Clinical Immunology
Open Access
Published: Apr 2021
122 citations
122 citations
224 days after retraction
Therapeutic potential and molecular mechanisms of mycophenolic acid as an anticancer agent
Juthipong Benjanuwattra, Parunya Chaiyawat, Dumnoensun Pruksakorn et al. (4 authors)
European Journal of Pharmacology
Published: Sep 2020
33 citations
33 citations
16 days after retraction
IMPDH2 promotes cell proliferation and epithelialāmesenchymal transition of nonāsmall cell lung cancer by activating the Wnt/βācatenin signaling pathway
Hao Xu, Hongda Ma, Lifen Zha et al. (10 authors)
Oncology Letters
Open Access
Published: Sep 2020
11 citations
11 citations
8 days after retraction
Quantitative analysis of differentially expressed proteins in psoriasis vulgaris using tandem mass tags and parallel reaction monitoring
Yu Li, Lin Peng, Siyao Wang et al. (7 authors)
Clinical Proteomics
Open Access
Published: Aug 2020
17 citations
17 citations
20 days before retraction
Shikonin is a novel and selective <scp>IMPDH2</scp> inhibitor that target tripleānegative breast cancer
Wanyan Wang, Yu Wu, Si Chen et al. (9 authors)
Phytotherapy Research
Published: Aug 2020
32 citations
32 citations
22 days before retraction
Antitumor potential of dark sweet cherry sweet (Prunus avium) phenolics in suppressing xenograft tumor growth of MDA-MB-453 breast cancer cells
Giuliana Noratto, Marjorie Anne Layosa, Nara Nunes Lage et al. (7 authors)
The Journal of Nutritional Biochemistry
Published: May 2020
12 citations
12 citations
96 days before retraction
The expression and prognostic role of IMPDH2 in ovarian cancer
Yuan Tian, Jing Zhang, Ling Chen et al. (4 authors)
Annals of Diagnostic Pathology
Published: Mar 2020
11 citations
11 citations
162 days before retraction
Paper citing IMPDH2 is highly expressed in breast cancer and pr...
Unknown Authors
Unknown Journal
Published: Feb 2020
213 days before retraction
<p>FANCI Cooperates with IMPDH2 to Promote Lung Adenocarcinoma Tumor Growth via a MEK/ERK/MMPs Pathway</p>
Pengchao Zheng, Lei Li
OncoTargets and Therapy
Open Access
Published: Jan 2020
20 citations
20 citations
244 days before retraction
Breast cancer survival prediction using seven prognostic biomarker genes
Liu Liu, Zhilin Chen, Wenjie Shi et al. (5 authors)
Oncology Letters
Open Access
Published: Jul 2019
23 citations
23 citations
411 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
5.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025